These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6387966)

  • 21. [Treatment of hypertension with a fixed combination of pindolol and clopamide (VKB-105)].
    Sekso M; Vizner B; Benković K
    Lijec Vjesn; 1984; 106(11-12):512-4. PubMed ID: 6394939
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of once daily beta-adrenoceptor blocker-thiazide diuretic combination on the ambulatory blood pressure.
    Gould BA; Hornung RS; Kieso H; Mann S; Raftery EB
    Br J Clin Pharmacol; 1982 Dec; 14(6):827-31. PubMed ID: 6129883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of once daily endralazine with placebo in the treatment of hypertension uncontrolled by a beta-blocker and diuretic.
    McGourty JC; Silas JH; Pidgeon J
    Eur J Clin Pharmacol; 1985; 29(4):401-3. PubMed ID: 2868900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patients compliance in hypertension--the importance of number of tablets.
    Asplund J; Danielson M; Ohman P
    Br J Clin Pharmacol; 1984 May; 17(5):547-52. PubMed ID: 6375710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of hypertension with a combination of prindolol and clopamide (author's transl)].
    Gábor G; Jávor T; Szám I; Török E
    MMW Munch Med Wochenschr; 1975 Nov; 117(46):1853-6. PubMed ID: 811982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antihypertensive action of a beta-blocker: value of a controlled therapeutic trial].
    Safar M; Maiz HB; Weiss Y; Lagrue G; Milliez P
    Therapeutique; 1973; 49(7):459-62. PubMed ID: 4150742
    [No Abstract]   [Full Text] [Related]  

  • 27. [Field study results of a fixed beta blockader-diuretic combination: effect of dosage reduction ("stepping down")].
    Wyrsch J; Bousquet JC
    Schweiz Rundsch Med Prax; 1983 Oct; 72(40):1279-81. PubMed ID: 6647391
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effectiveness of Viskaldix in patients with primary hypertension].
    Cybulska I; Sznajderman M
    Pol Tyg Lek; 1983 Nov; 38(45):1399-401. PubMed ID: 6374634
    [No Abstract]   [Full Text] [Related]  

  • 29. A comparative trial of fixed ratio beta-adrenoceptor blocker and diuretic combination products in moderate hypertension.
    Watt SJ; Lee MR
    Pharmatherapeutica; 1980; 2(7):487-93. PubMed ID: 6111083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of the combination of Pindolol and clopamide in systemic arterial hypertension. A multicenter study].
    Zilenovski AM; Freire CA
    Arq Bras Cardiol; 1981 Sep; 37(3):219-24. PubMed ID: 7052028
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of once daily endralazine in hypertension.
    Wu R; Spence JD; Carruthers SG
    Eur J Clin Pharmacol; 1986; 30(5):553-7. PubMed ID: 3758143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of pindolol and clopamide on blood lipids in arterial hypertensive patients.
    Román O; Pino ME; Valenzuela A
    Cardiology; 1987; 74(3):219-25. PubMed ID: 3594511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Viskaldix in the treatment of arterial hypertension].
    Josipović V; Stefanović M; Kozarević D; Kozarević D; Knezević S
    Lijec Vjesn; 1984; 106(11-12):523-5. PubMed ID: 6394942
    [No Abstract]   [Full Text] [Related]  

  • 34. [Evaluation of the hypotensive effect of Viskaldix].
    Wyrzykowski B; Suchecka-Rachoń K; Krupa-Wojciechowska B
    Przegl Lek; 1985; 42(11):750-4. PubMed ID: 3912842
    [No Abstract]   [Full Text] [Related]  

  • 35. Endralazine, a new peripheral vasodilator. Evaluation of safety and efficacy over a 3 year period.
    Bogers WA; Meems L
    Eur J Clin Pharmacol; 1983; 24(3):301-5. PubMed ID: 6861845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study of the antihypertensive effect of the preparation VKB-105 (Viskaldix) in arterial hypertension].
    Ivancić R; Goldner V; Jursić M; Uchytil R; Strbo B
    Lijec Vjesn; 1984; 106(11-12):520-2. PubMed ID: 6394941
    [No Abstract]   [Full Text] [Related]  

  • 37. ["Viskaldix" in the treatment of arterial hypertension].
    Bar-Andziak E; Brym E; Czerniewska E
    Kardiol Pol; 1984; 27(2):125-30. PubMed ID: 6374243
    [No Abstract]   [Full Text] [Related]  

  • 38. [Viskaldix for treatment of patients with moderate arterial hypertension. Comparative estimation of hemodynamic changes during treatment with Viskaldix and Stresson].
    Grajek S; Szymczyńska A; Urbański K; Lehman Z; Kozłowska F; Paradowski S; Gracz M
    Kardiol Pol; 1986; 29(7):440-53. PubMed ID: 2879953
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical evaluation of endralazine (BO22708), a new vasodilator, in essential hypertension.
    Elliott HL; McLean K; Sumner DJ; Donnelly RJ; Reid JL
    Clin Exp Hypertens A; 1982; 4(8):1409-18. PubMed ID: 6749347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endralazine, a new peripheral vasodilator--a randomized cross-over trial against dihydralazine.
    Kirch W; Axthelm T
    J Cardiovasc Pharmacol; 1982; 4(4):562-6. PubMed ID: 6181329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.